Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin

References

• Ahmad DS, Faulx A. Management of Postcholecystectomy Biliary Complications: a Narrative Review. Am J Gastroenterol. 2020;115(8):1191–19. doi:10.14309/ajg.0000000000000704.
   PubMed Web of Science ®Google Scholar
• Farrugia A, Attard JA, Hanmer S, Bullock S, McKay S, Al-Azzawi M, Ali R, Bond-Smith G, Colleypriest B, Dyer S, et al. Rates of Bile Acid Diarrhoea After Cholecystectomy: a Multicentre Audit. World J Surg. 2021;45(8):2447–2453. doi:10.1007/s00268-021-06147-8.
   PubMed Web of Science ®Google Scholar
• Lammert F, Gurusamy K, Ko CW, Miquel JF, Mendez-Sanchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ. Gallstones. Nat Rev Dis Primers. 2016;2(16024). doi:10.1038/nrdp.2016.24.
   PubMedGoogle Scholar
• Fort M, Azpiroz F, Casellas F, Andreu J, Malagelada JR. Bowel Habit After Cholecystectomy: physiological Changes and Clinical Implications. Gastroenterology. 1996;111(3):617–622. doi:10.1053/gast.1996.v111.pm8780565.
   PubMed Web of Science ®Google Scholar
• Damsgaard B, Dalby HR, Krogh K, Jørgensen SMD, Arveschough AK, Agnholt J, Dahlerup JF, Jørgensen SP. Long-term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study. Aliment Pharmacol Ther. 2018;47(7):951–957. doi:10.1111/apt.14533.
   PubMed Web of Science ®Google Scholar
• Mars RAT, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, Tang X, Sun Z, Kalari KR, Korem T, et al. Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome. Cell. 2020;182(6):1460–1473 e1417. doi:10.1016/j.cell.2020.08.007.
   PubMed Web of Science ®Google Scholar
• Sommer F, Backhed F. The gut microbiota–masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–238. doi:10.1038/nrmicro2974.
   PubMed Web of Science ®Google Scholar
• Xu Y, Jing H, Wang J, Zhang S, Chang Q, Li Z, Wu X, Zhang Z. Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Front Microbiol. 2022:13. doi:10.3389/fmicb.2022.800604.
   Web of Science ®Google Scholar
• Li YD, Liu BN, Zhao SH, Zhou YL, Bai L, Liu EQ. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea. World J Gastroenterol. 2021;27(5):391–403. doi:10.3748/wjg.v27.i5.391.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Kim HN, Park E, Ryu S, Chang Y, Shin H, Kim HL, Yi SY. The Impact of Cholecystectomy on the Gut Microbiota: a Case-Control Study. J Clin Med. 2019;8(1):79. doi:10.3390/jcm8010079.
   PubMed Web of Science ®Google Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–478. doi:10.1038/s41575-019-0157-3.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Ge X, Ding C, Zhao W, Xu L, Tian H, Gong J, Zhu M, Li J, Li N. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med. 2017;15(1):13. doi:10.1186/s12967-016-1105-4.
   PubMedGoogle Scholar
• Yano Jessica M, Yu K, Donaldson Gregory P, Shastri Gauri G, Ann P, Ma L, Nagler Cathryn R, Ismagilov Rustem F, Mazmanian Sarkis K, Hsiao Elaine Y. Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell. 2015;161(2):264–276. doi:10.1016/j.cell.2015.02.047.
   PubMed Web of Science ®Google Scholar
• Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65(1):57–62. doi:10.1136/gutjnl-2015-309618.
   PubMed Web of Science ®Google Scholar
• Sun S, Jones RB, Fodor AA. Inference-based accuracy of metagenome prediction tools varies across sample types and functional categories. Microbiome. 2020;8(1):46. doi:10.1186/s40168-020-00815-y.
   PubMed Web of Science ®Google Scholar
• Wu S, Xu C, Liu J, Liu C, Qiao J. Vertical and horizontal quorum-sensing-based multicellular communications. Trends Microbiol. 2021;29(12):1130–1142. doi:10.1016/j.tim.2021.04.006.
   PubMed Web of Science ®Google Scholar
• Mawe GM, Hoffman JM. Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473–486. doi:10.1038/nrgastro.2013.105.
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J. The Serotonin Signaling System: from Basic Understanding To Drug Development for Functional GI Disorders. Gastroenterology. 2007;132(1):397–414. doi:10.1053/j.gastro.2006.11.002.
   PubMed Web of Science ®Google Scholar
• Bhattarai Y, Williams BB, Battaglioli EJ, Whitaker WR, Till L, Grover M, Linden DR, Akiba Y, Kandimalla KK, Zachos NC, et al. Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. Cell Host Microbe. 2018;23(6):775–785 e775. doi:10.1016/j.chom.2018.05.004.
   PubMed Web of Science ®Google Scholar
• Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K, Ungethüm U, Kobold S, Graf R, et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci Transl Med. 2021;13(611):eabc8188.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000;355(9209):1035–1040. doi:10.1016/s0140-6736(00)02033-x.
   PubMed Web of Science ®Google Scholar
• Spohn SN, Bianco F, Scott RB, Keenan CM, Linton AA, O’Neill CH, Bonora E, Dicay M, Lavoie B, Wilcox RL, et al. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon. Gastroenterology. 2016;151(5):933–944 e933. doi:10.1053/j.gastro.2016.07.032.
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang W, Chen Y, Huang F, Lu L, Lin C, Huang T, Ning Z, Zhai L, Zhong LL, et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 2020;130(1):438–450. doi:10.1172/JCI130976.
   PubMed Web of Science ®Google Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–669. doi:10.1016/j.cmet.2013.03.013.
   PubMed Web of Science ®Google Scholar
• Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, Sun D, Ren Z, Li M, Zhao M, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33(4):791–803 e797. doi:10.1016/j.cmet.2020.11.017.
   PubMed Web of Science ®Google Scholar
• Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, Sano Y, Inamura K, Matsushime H, Koizumi T, et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A. 2009;106(9):3408–3413. doi:10.1073/pnas.0805323106.
   PubMed Web of Science ®Google Scholar
• Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C, O’Donnell TA, Brierley SM, Ingraham HA, Julius D. Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways. Cell. 2017;170(1):185–198 e116. doi:10.1016/j.cell.2017.05.034.
   PubMed Web of Science ®Google Scholar
• Li N, Koester ST, Lachance DM, Dutta M, Cui JY, Dey N. Microbiome-encoded bile acid metabolism modulates colonic transit times. iScience. 2021;24(6):102508. doi:10.1016/j.isci.2021.102508.
   PubMed Web of Science ®Google Scholar
• Lieu T, Jayaweera G, Zhao P, Poole DP, Jensen D, Grace M, McIntyre P, Bron R, Wilson YM, Krappitz M, et al. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Gastroenterology. 2014;147(6):1417–1428. doi:10.1053/j.gastro.2014.08.042.
   PubMed Web of Science ®Google Scholar
• Jing H, Chang Q, Xu Y, Wang J, Wu X, Huang J, Wang L, Zhang Z. Effect of aging on acute pancreatitis through gut microbiota. Front Microbiol. 2022;13:897992. doi:10.3389/fmicb.2022.897992.
   PubMed Web of Science ®Google Scholar
• Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472). doi:10.1126/scitranslmed.aap8914
   PubMed Web of Science ®Google Scholar
• Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2006;130(1):34–43. doi:10.1053/j.gastro.2005.09.031.
   PubMed Web of Science ®Google Scholar
• Gao J, Xiong T, Grabauskas G, Owyang C. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2. Gastroenterology. 2022;162(7):1962–1974 e1966. doi:10.1053/j.gastro.2022.02.016.
   PubMed Web of Science ®Google Scholar
• Spohn SN, Mawe GM. Non-conventional features of peripheral serotonin signalling - the gut and beyond. Nat Rev Gastroenterol Hepatol. 2017;14(7):412–420. doi:10.1038/nrgastro.2017.51.
   PubMed Web of Science ®Google Scholar
• Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11(2):158–171. doi:10.1080/19490976.2019.1674124.
   PubMed Web of Science ®Google Scholar
• Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, Guo C, Higginbottom S, Almo SC, Fischbach MA. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature. 2020;582(7813):566–570. doi:10.1038/s41586-020-2396-4.
   PubMed Web of Science ®Google Scholar
• Gershon MD, Margolis KG. The gut, its microbiome, and the brain: connections and communications. J Clin Invest. 2021;131(18). doi:10.1172/JCI143768.
   Web of Science ®Google Scholar
• Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2009;104(7):1831–1843. doi:10.1038/ajg.2009.223.
   PubMed Web of Science ®Google Scholar
• Fukudo S, Kinoshita Y, Okumura T, Ida M, Akiho H, Nakashima Y, Nishida A, Haruma K. Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women. Gastroenterology. 2016;150(2):358–366 e358. doi:10.1053/j.gastro.2015.10.047.
   PubMed Web of Science ®Google Scholar
• Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G, Henry A, Hall I, Whorwell P, Spiller R. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63(10):1617–1625. doi:10.1136/gutjnl-2013-305989.
   PubMed Web of Science ®Google Scholar
• Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, Zhao H, Swain GM, Moses PL, Galligan JJ, et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology. 2012;142(4):844–854 e844. doi:10.1053/j.gastro.2011.12.041.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Horsch D, Caplin ME, Anthony LB, Bergsland E, Oberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL, et al. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. J Clin Oncol. 2017;35(1):14–23. doi:10.1200/JCO.2016.69.2780.
   PubMed Web of Science ®Google Scholar
• Chen Z, Luo J, Li J, Kim G, Stewart A, Urban JF Jr., Huang Y, Chen S, Wu LG, Chesler A, et al. Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis. Immunity. 2021;54(1):151–163 e156. doi:10.1016/j.immuni.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology. 2013;144(1):145–154. doi:10.1053/j.gastro.2012.09.055.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang S, Kobayashi K, Hao Y, Kanda H, Kondo T, Kogure Y, Yamanaka H, Yamamoto S, Li J, et al. TRPA1-expressing lamina propria mesenchymal cells regulate colonic motility. JCI Insight. 2019;4(9):5.
   Web of Science ®Google Scholar
• Vaughn BP, Rank KM, Khoruts A. Fecal Microbiota Transplantation: current Status in Treatment of GI and Liver Disease. Clin Gastroenterol Hepatol. 2019;17(2):353–361. doi:10.1016/j.cgh.2018.07.026.
   PubMed Web of Science ®Google Scholar
• Benech N, Sokol H. Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine. Genome Med. 2020;12(1):58. doi:10.1186/s13073-020-00757-y.
   PubMed Web of Science ®Google Scholar
• Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, Major G, O’Connor M, Sanders DS, Sinha R, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology. 3rd. Gut. 2018;67(8):1380–1399. doi:10.1136/gutjnl-2017-315909.
   PubMed Web of Science ®Google Scholar
• Smalley W, Falck-Ytter C, Carrasco-Labra A, Wani S, Lytvyn L, Falck-Ytter Y. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D). Gastroenterology. 2019;157(3):851–854. doi:10.1053/j.gastro.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Golubeva AV, Joyce SA, Moloney G, Burokas A, Sherwin E, Arboleya S, Flynn I, Khochanskiy D, Moya-Perez A, Peterson V, et al. Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism. EBioMedicine. 2017;24:166–178. doi:10.1016/j.ebiom.2017.09.020.
   PubMed Web of Science ®Google Scholar
• Al-Saffar A, Takemi S, Saaed HK, Sakata I, Sakai T. Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2019:40–41. doi:10.1016/j.bpg.2019.101633.
   Web of Science ®Google Scholar
• Cao H, Liu X, An Y, Zhou G, Liu Y, Xu M, Dong W, Wang S, Yan F, Jiang K, et al. Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Sci Rep. 2017;7(1):10322. doi:10.1038/s41598-017-10835-8.
   PubMedGoogle Scholar
• Heredia DJ, Gershon MD, Koh SD, Corrigan RD, Okamoto T, Smith TK. Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1. J Physiol. 2013;591(23):5939–5957. doi:10.1113/jphysiol.2013.256230.
   PubMed Web of Science ®Google Scholar
• Zhang SL, Mao YQ, Zhang ZY, Li ZM, Kong CY, Chen HL, Cai PR, Han B, Ye T, Wang LS. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Theranostics. 2021;11(9):4155–4170. doi:10.7150/thno.54476.
   PubMed Web of Science ®Google Scholar
• Lin JX, Xie XS, Weng XF, Zheng CH, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, et al. The prognostic value of Cyclin-Dependent Kinase 5 and Protein Phosphatase 2A in Gastric Cancer. J Cancer. 2018;9(23):4404–4412. doi:10.7150/jca.27015.
   PubMed Web of Science ®Google Scholar
• Tian P, O’Riordan KJ, Lee YK, Wang G, Zhao J, Zhang H, Cryan JF, Chen W. Towards a psychobiotic therapy for depression: bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiol Stress. 2020;12:100216. doi:10.1016/j.ynstr.2020.100216.
   PubMed Web of Science ®Google Scholar
• Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG. A Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of 0.5 mg and 1 mg Alosetron in Women With Severe Diarrhea-predominant IBS. Am J Gastroenterol. 2007;102(8):1709–1719. doi:10.1111/j.1572-0241.2007.01282.x.
   PubMed Web of Science ®Google Scholar